News

Investment

Tech founders rally into Ultrahuman funding round

Artificial heart developer CARMAT beats €40.5 million funding goal

Juvenescence and Buck Institute launch company to target heart disease

Selah Therapeutics will focus on developing novel ketone-based therapies for chronic diseases of aging, with heart disease as primary focus.

Kizoo portfolio company Elastrin Therapeutics closes $10 million funding round

Fauna Bio partners with UW Oshkosh in search for novel therapies for disease

Rejuvenate Biomed starts groundbreaking sarcopenia trial with eye on future growth

Genflow collaborates with Aging Research Centre to drive sirtuin research

Strategic partnership plans disruptive, personalised AI engine to counter skin aging

Moon Rabbit partners with Foresight to accelerate longevity ideas into reality

Juvenescence targets fibrotic disease with new investment

Revel announces $8.4m for repairing-based approaches to reversing aging

Genflow receives grant award to accelerate longevity research

New partnership set to use AI to accelerate regenerative medicine

NIH and DoD-backed Ridgeline targets muscle decline

International Women’s Day: the wonderful women of longevity

Exogenus and Boehringer Ingelheim in regenerative medicine collaboration

Life insurance epigenetics start-up Foxo plans IPO via SPAC

New innovation longevity research prize launched

The state of longevity – clinical trials progress gathers pace

Crunching the longevity numbers – 2021 investment shows the market is booming

Apollo partners with VitaDAO and Molecule on Web3 for longevity biotech

Next gen rapalogs – Cambrian Biopharma announces mTOR inhibitors licensing agreement

Building new oncology therapeutics with longevity potential

Rosita Longevity over 60s health app launches in US

Johnson & Johnson bags rapamycin analog biotech Anakuria

Cellino bags $80 million to autonomise stem cell therapy manufacturing

NURO embarks on funding round for neurotech communication system

Mental illness drug discovery company Neurai Life Sciences launches

Altos Labs lands $3 billion to further cellular rejuvenation programming

StarkAge secures 2 million euros for senescence targeting therapy

Cytosurge wins funding to address bottlenecks in neuroscience research

Genflow IPO “starts a new chapter” for longevity biotech

Find us here ...